Just when things were beginning to turn rosy, developments involving the proposed TRIPS waiver of patent rights for Covid-19 drugs, vaccines and devised have once again taken a downturn. In the middle of 2021, WTO members decided to begin text-based negotiations on the waiver and were expected to release a report by July 22, 2021. Discussions had come to a halt and no report was issued. Read more
Tuesday, January 4 2022 \ Published by Asia IP Law.